Re-Vana Therapeutics ^Companies

Re-Vana Therapeutics is an ocular pharmaceuticals and drug delivery company that focuses on developing and commercializing long-acting, biodegradable drug delivery platforms for ophthalmic conditions such as age-related macular degeneration, diabetic retinopathy, glaucoma, and ocular infections. Their platform technologies enable tailored delivery of therapeutics for long-term use and can be administered through various routes to the eye. They have two main platforms, OcuLief™ and EyeLief™, which can be customized for the treatment of different eye diseases and achieve sustained release of drugs for up to 12 months. Re-Vana's goal is to increase patient compliance, reduce side effects, and provide cost savings for healthcare providers and pharmaceutical companies through their innovative drug delivery systems.